JPY 1176.0
(-0.17%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 98 Billion JPY | 25.88% |
2022 | 77.85 Billion JPY | 21.78% |
2021 | 63.93 Billion JPY | -2.76% |
2020 | 65.75 Billion JPY | 94.72% |
2019 | 33.76 Billion JPY | -5.49% |
2018 | 35.72 Billion JPY | 13.0% |
2017 | 31.61 Billion JPY | -8.77% |
2016 | 34.65 Billion JPY | 13.76% |
2015 | 30.46 Billion JPY | -9.71% |
2014 | 33.73 Billion JPY | -1.54% |
2013 | 34.26 Billion JPY | 8.88% |
2012 | 31.47 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 99.06 Billion JPY | 1.08% |
2023 Q4 | 98 Billion JPY | 4.74% |
2023 Q1 | 95.53 Billion JPY | 22.7% |
2023 FY | 98 Billion JPY | 25.88% |
2023 Q2 | 96 Billion JPY | 0.49% |
2023 Q3 | 93.57 Billion JPY | -2.53% |
2022 FY | 77.85 Billion JPY | 21.78% |
2022 Q4 | 77.85 Billion JPY | 1.73% |
2022 Q3 | 76.53 Billion JPY | -1.54% |
2022 Q2 | 77.73 Billion JPY | 1.27% |
2022 Q1 | 76.75 Billion JPY | 20.05% |
2021 Q2 | 66.2 Billion JPY | 3.11% |
2021 Q3 | 64.83 Billion JPY | -2.06% |
2021 Q4 | 63.93 Billion JPY | -1.39% |
2021 Q1 | 64.2 Billion JPY | -2.35% |
2021 FY | 63.93 Billion JPY | -2.76% |
2020 Q2 | 38.61 Billion JPY | -0.42% |
2020 Q4 | 65.75 Billion JPY | 53.77% |
2020 Q1 | 38.77 Billion JPY | 14.84% |
2020 Q3 | 42.75 Billion JPY | 10.73% |
2020 FY | 65.75 Billion JPY | 94.72% |
2019 Q2 | 36.17 Billion JPY | -9.65% |
2019 FY | 33.76 Billion JPY | -5.49% |
2019 Q3 | 34.33 Billion JPY | -5.08% |
2019 Q4 | 33.76 Billion JPY | -1.65% |
2019 Q1 | 40.03 Billion JPY | 12.06% |
2018 FY | 35.72 Billion JPY | 13.0% |
2018 Q4 | 35.72 Billion JPY | -2.77% |
2018 Q3 | 36.74 Billion JPY | -1.22% |
2018 Q2 | 37.19 Billion JPY | -1.2% |
2018 Q1 | 37.64 Billion JPY | 19.08% |
2017 Q2 | 35.5 Billion JPY | -0.91% |
2017 Q1 | 35.82 Billion JPY | 3.38% |
2017 FY | 31.61 Billion JPY | -8.77% |
2017 Q4 | 31.61 Billion JPY | -3.34% |
2017 Q3 | 32.7 Billion JPY | -7.87% |
2016 Q2 | 33.12 Billion JPY | 9.53% |
2016 Q4 | 34.65 Billion JPY | 0.71% |
2016 Q3 | 34.4 Billion JPY | 3.89% |
2016 Q1 | 30.24 Billion JPY | -0.72% |
2016 FY | 34.65 Billion JPY | 13.76% |
2015 Q3 | 29.98 Billion JPY | -0.13% |
2015 Q4 | 30.46 Billion JPY | 1.6% |
2015 Q1 | 32.45 Billion JPY | -3.8% |
2015 FY | 30.46 Billion JPY | -9.71% |
2015 Q2 | 30.02 Billion JPY | -7.5% |
2014 FY | 33.73 Billion JPY | -1.54% |
2014 Q4 | 33.73 Billion JPY | 0.0% |
2013 FY | 34.26 Billion JPY | 8.88% |
2012 FY | 31.47 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
JINS HOLDINGS Inc. | 28.44 Billion JPY | -244.52% |
Medius Holdings Co., Ltd. | 95.08 Billion JPY | -3.07% |
Ship Healthcare Holdings, Inc. | 244.6 Billion JPY | 59.931% |
JTEC Corporation | 870.74 Million JPY | -11155.777% |
Hogy Medical Co.,Ltd. | 13.91 Billion JPY | -604.138% |
Kawamoto Corporation | 11.79 Billion JPY | -730.681% |
Terumo Corporation | 504.3 Billion JPY | 80.566% |
KAINOS Laboratories, Inc. | 2.32 Billion JPY | -4115.987% |
JAPAN EYEWEAR HOLDINGS CO LTD | 21.49 Billion JPY | -355.941% |
Sysmex Corporation | 186.02 Billion JPY | 47.313% |
JMS Co.,Ltd. | 43.95 Billion JPY | -122.966% |
Nakanishi Inc. | 27.51 Billion JPY | -256.24% |
Mani, Inc. | 4.84 Billion JPY | -1922.89% |
Olympus Corporation | 775.55 Billion JPY | 87.363% |
HOYA Corporation | 241.35 Billion JPY | 59.393% |
SEED Co.,Ltd. | 31.92 Billion JPY | -207.007% |
Asahi Intecc Co., Ltd. | 39.65 Billion JPY | -147.185% |
Medikit Co.,Ltd. | 6.87 Billion JPY | -1326.429% |
Daiken Medical Co., Ltd. | 3.98 Billion JPY | -2360.162% |
Sincere Co., LTD. | 2.91 Billion JPY | -3259.925% |
Platz Co., Ltd. | 3.07 Billion JPY | -3082.196% |
Paramount Bed Holdings Co., Ltd. | 44 Billion JPY | -122.738% |
Shofu Inc. | 8.48 Billion JPY | -1055.494% |
Shigematsu Works Co., Ltd. | 7.81 Billion JPY | -1154.355% |
Nipro Corporation | 849.17 Billion JPY | 88.458% |
ASO International, Inc. | 421.74 Million JPY | -23138.869% |